SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2208)2/20/2008 2:55:19 PM
From: Jibacoa  Respond to of 3722
 
LMRA is up 18.97% after news, but not related to its Plexera Biotech division.<g>

bigcharts.marketwatch.com

It announced today that it had entered into an agreement with Asyrmatos, a privately held Boston-based company, to develop telecommunication products that will be enabled by LMRA’s millimeter wave communication technology.

LMRA will acquire 25% of Asyrmatos in exchange for the intellectual property associated with the technology & willl have a seat on Asyrmatos’ board & an option to acquire the outstanding stock of Asyrmatos in 2012.

The stock has now closed its Jan 29 UG & needs to close above the resistance at the $3 level before retesting the Jan 29 H

bigcharts.marketwatch.com

I will keep my target at $5 <g>

bigcharts.marketwatch.com

Bernard